Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: KLB003
MIFTS: 36

Klebsiella Pneumonia

Categories: Infectious diseases, Respiratory diseases
Genes Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Klebsiella Pneumonia

About this section

MalaCards integrated aliases for Klebsiella Pneumonia:

Name: Klebsiella Pneumonia 12 56 15
Klebsiella Infections 45 17
Pneumonia Due to Klebsiella Pneumoniae 12

Classifications:

MalaCards categories:
Global: Infectious diseases
Anatomical: Respiratory diseases
See all MalaCards categories (disease lists)
ICD10: 34


External Ids:

Disease Ontology 12 DOID:13272
ICD9CM 36 482.0
MeSH 45 D007710
ICD10 34 B96.1 J15.0
Sources

Summaries for Klebsiella Pneumonia

About this section
Disease Ontology : 12 A bacterial pneumonia involving Klebsiella pneumoniae infection. Patients with Klebsiella pneumonia tend to cough up a characteristic sputum that is said to resemble \

MalaCards based summary : Klebsiella Pneumonia, also known as klebsiella infections, is related to craniosynostosis 1 and klebsiella infection. An important gene associated with Klebsiella Pneumonia is CCR6 (C-C Motif Chemokine Receptor 6). The drugs Colistin and Chlorhexidine have been mentioned in the context of this disorder. Affiliated tissues include liver, colon and kidney.

Wikipedia : 77 Klebsiella pneumoniae is a Gram-negative, non-motile, encapsulated, lactose-fermenting, facultative... more...

Sources

Related Diseases for Klebsiella Pneumonia

About this section

Diseases related to Klebsiella Pneumonia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 172)
# Related Disease Score Top Affiliating Genes
1 craniosynostosis 1 11.3
2 klebsiella infection 11.3
3 keratoconus posticus circumscriptus 11.2
4 cerebrotendinous xanthomatosis 11.0
5 pneumonia 10.9
6 endophthalmitis 10.8
7 meningitis 10.6
8 acute cystitis 10.6
9 fasciitis 10.5
10 necrotizing fasciitis 10.5
11 spondylitis 10.4
12 spondyloarthropathy 1 10.4
13 arthritis 10.4
14 tetralogy of fallot 10.4
15 osteomyelitis 10.4
16 septic arthritis 10.4
17 peritonitis 10.4
18 blood group, colton system 10.3
19 burns 10.3
20 diabetes mellitus 10.3
21 mastitis 10.3
22 endocarditis 10.3
23 lung abscess 10.3
24 cystitis 10.3
25 aplasia cutis congenita, nonsyndromic 10.3
26 epidural abscess 10.3
27 pyelonephritis 10.3
28 diarrhea 10.2
29 cellulitis 10.2
30 leukemia 10.2
31 neutropenia 10.2
32 bacteriuria 10.2
33 splenic abscess 10.2
34 pyomyositis 10.2
35 anterior uveitis 10.2
36 rheumatoid arthritis 10.1
37 enterocolitis 10.1
38 bacterial infectious disease 10.1
39 orbital cellulitis 10.1
40 lemierre's syndrome 10.1
41 uveitis 10.1
42 pleural empyema 10.1
43 mediastinitis 10.1
44 haemophilus influenzae 10.1
45 neutrophil actin dysfunction 10.1
46 sickle cell anemia 10.1
47 hematopoietic stem cell transplantation 10.1
48 liver cirrhosis 10.1
49 spinal cord injury 10.1
50 hypopyon 10.1

Graphical network of the top 20 diseases related to Klebsiella Pneumonia:



Diseases related to Klebsiella Pneumonia
Sources

Symptoms & Phenotypes for Klebsiella Pneumonia

About this section
Sources

Drugs & Therapeutics for Klebsiella Pneumonia

About this section

Drugs for Klebsiella Pneumonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 118)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Colistin Approved Phase 4,Phase 3,Not Applicable 1066-17-7, 1264-72-8 5311054
2
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2 55-56-1 2713 9552079
3
Ertapenem Approved, Investigational Phase 4,Phase 2,Phase 3 153832-46-3 150610
4
leucovorin Approved Phase 4,Phase 3,Phase 2 58-05-9 143 6006
5
Sulfamethoxazole Approved Phase 4,Phase 2 723-46-6 5329
6
Trimethoprim Approved, Vet_approved Phase 4,Phase 2 738-70-5 5578
7
Ceftriaxone Approved Phase 4,Not Applicable 73384-59-5 5479530 5361919
8
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable 85721-33-1 2764
9
Piperacillin Approved Phase 4,Phase 3 66258-76-2 43672
10
Tazobactam Approved Phase 4,Phase 3 89786-04-9 123630
11
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
12
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
13
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
14
Polyestradiol phosphate Approved Phase 4 28014-46-2
15
Cephalexin Approved, Investigational, Vet_approved Phase 4,Phase 2 15686-71-2 27447
16
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
17
Meropenem Approved, Investigational Phase 4,Phase 3,Early Phase 1 119478-56-7, 96036-03-2 441130 64778
18
Mupirocin Approved, Investigational, Vet_approved Phase 4 12650-69-0 446596
19
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2 59-30-3 6037
20 Gentamicins Phase 4,Not Applicable
21 Polymyxins Phase 4,Phase 3,Not Applicable,Early Phase 1
22 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
23 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
24 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
25 Antitubercular Agents Phase 4,Not Applicable,Early Phase 1
26 Pharmaceutical Solutions Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
27 Dermatologic Agents Phase 4,Phase 3,Phase 2
28 Disinfectants Phase 4,Phase 3,Phase 2
29 Anti-Infective Agents, Local Phase 4,Phase 3,Phase 2,Not Applicable
30 methicillin Phase 4
31 Chlorhexidine gluconate Phase 4,Phase 3,Phase 2
32 Antiprotozoal Agents Phase 4,Phase 3,Phase 2
33 Vitamin B Complex Phase 4,Phase 3,Phase 2
34 Folate Phase 4,Phase 3,Phase 2
35 Trimethoprim, Sulfamethoxazole Drug Combination Phase 4,Phase 2
36 Anti-Infective Agents, Urinary Phase 4,Phase 3,Phase 2
37 Vitamin B9 Phase 4,Phase 3,Phase 2
38 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable
39 Cytochrome P-450 CYP1A2 Inhibitors Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable
40 Antimalarials Phase 4,Phase 2
41 Antiparasitic Agents Phase 4,Phase 3,Phase 2
42 Folic Acid Antagonists Phase 4,Phase 3,Phase 2
43 Liver Extracts Phase 4
44 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable
45 Renal Agents Phase 4,Phase 3,Phase 2
46 Piperacillin, Tazobactam Drug Combination Phase 4,Phase 3
47 beta-Lactamase Inhibitors Phase 4,Phase 3
48 Cephalosporins Phase 4
49 Bifidobacterium Phase 4,Not Applicable
50 Norgestimate, ethinyl estradiol drug combination Phase 4

Interventional clinical trials:

(show top 50) (show all 103)
# Name Status NCT ID Phase Drugs
1 SDD for Eradicating CRKP Carriage Unknown status NCT01761487 Phase 4
2 Safety and Efficacy Study of High Dose Colistin Unknown status NCT02162966 Phase 4 High Dose Colistin;Standard Dose Colistin
3 Antibiotics for Klebsiella Liver Abscess Study Completed NCT01723150 Phase 4 Ciprofloxacin;Ceftriaxone;Trimethoprim/sulfamethoxazole;Ertapenem
4 Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs) Completed NCT00254696 Phase 4 Extended-Spectrum-Lactamases (ESBLs)
5 Tazocin Intervention Study Completed NCT00478855 Phase 4 Tazocin (Piperacillin/Tazobactem)
6 Study Evaluation Tazocin Intervention Completed NCT00488189 Phase 4 Tazocin (pipercillin/tazobactam)
7 Study of Antibiotic Utilization Measures and Control of ESBLs in China Completed NCT00488813 Phase 4 Third generation cephalosporins
8 NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants Completed NCT03219931 Phase 4 Bifidobacterium breve BR03 and Bifidobacterium breve B632;Placebos
9 Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess Completed NCT00895089 Phase 4 Moxifloxacin (Avelox);ceftriaxone
10 Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae Recruiting NCT03891433 Phase 4 Meropenem;Ertapenem 1000 MG;Piperacillin, Tazobactam 4-0.5G Solution for Injection
11 Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Recruiting NCT02787863 Phase 4 Polioxidonium
12 Preventing Recurrent Urinary Tract Infections With α-D-mannose Recruiting NCT03497598 Phase 4 Mannose;Lactose
13 RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp. Terminated NCT02176122 Phase 4 Meropenem;Piperacillin-tazobactam combination product
14 Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD") Terminated NCT00747461 Phase 4
15 Effectiveness of Two Protocols for Corporal Decolonization in Patients Colonized by Methicillin Resistant Staphylococcus Aureus (MRSA) Terminated NCT01400308 Phase 4 Mupirocin + Chlorhexidin
16 Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli Unknown status NCT00300560 Phase 3 Colistin
17 Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Unknown status NCT01817075 Phase 3 Chlorhexidine Gluconate
18 Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn Unknown status NCT00136370 Phase 3 Chlorhexidine
19 Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms Completed NCT00079989 Phase 3 tigecycline
20 Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis Completed NCT03047954 Phase 3 Broncho-Vaxom;Placebo - Cap
21 Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP Completed NCT02166476 Phase 3 Meropenem-Vaborbactam;Piperacillin-Tazobactam;Levofloxacin;Saline
22 Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens Completed NCT01644643 Phase 3 Ceftazidime - Avibactam ( CAZ-AVI);Best Available Therapy;Metronidazole
23 Efficacy Of Bacterial Lysate In Asthmatic Children Completed NCT02541331 Phase 3
24 A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants Completed NCT01941940 Phase 3 Tocilizumab;DMARDs
25 Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli Recruiting NCT01597973 Phase 3 colistin and meropenem;colistin and placebo
26 Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens Recruiting NCT03159078 Phase 3 Polymyxin B
27 Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients Active, not recruiting NCT02729116 Phase 2, Phase 3 Sitafloxacin;Ertapenem
28 A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia Terminated NCT01110421 Phase 3 Cefepime placebo;Cefepime;Doripenem;Doripenem placebo;Amoxicillin/clavulanate potassium
29 Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia Unknown status NCT00722410 Phase 1, Phase 2 Polyethylene glycol
30 Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers Unknown status NCT02307383 Phase 2 Lactitol;Lactobacillus
31 Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients Completed NCT00123123 Phase 2 chlorhexidine gluconate oral rinse (0.12%);placebo
32 Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis Completed NCT00930982 Phase 2 Ciprofloxacin (Cipro, BAYQ3939);Placebo
33 The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children" Recruiting NCT01595529 Phase 2 Cefixime;Cephalexin;Trimethoprim/Sulfamethoxazole
34 Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness Recruiting NCT02148796 Phase 2 Broncho-Vaxom
35 Pentaglobin in CRE and PA Neutropenic Infections Not yet recruiting NCT03494959 Phase 2 Pentaglobin
36 A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects Completed NCT01262885 Phase 1 GSK2251052;Placebo
37 An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects Completed NCT01267968 Phase 1 GSK2251052
38 Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents Completed NCT01033383 Phase 1
39 Single and Multiple Dose Evaluation of QBKPN SSI In Healthy Volunteers Withdrawn NCT02897999 Phase 1
40 Microbiology and Clinical Outcome of Pneumonia Unknown status NCT00873522
41 Stool Transplantation to Reduce Antibiotic Resistance Transmission Unknown status NCT02461199
42 Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora Unknown status NCT01428999 Not Applicable
43 Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change Unknown status NCT01392118
44 Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards Unknown status NCT02456818
45 A Randomized Trial Comparing Matt and Antimicrobial Cellomed Laminates Unknown status NCT01245829 Not Applicable
46 SATURN 04 Nosocomial Acquisition Study Unknown status NCT01208519
47 Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread Unknown status NCT02666274
48 Experimental Phage Therapy of Bacterial Infections Unknown status NCT00945087 Not Applicable
49 Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting Unknown status NCT02339077
50 The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy Completed NCT01612182

Search NIH Clinical Center for Klebsiella Pneumonia

Cochrane evidence based reviews: klebsiella infections

Sources

Genetic Tests for Klebsiella Pneumonia

About this section
Sources

Anatomical Context for Klebsiella Pneumonia

About this section

MalaCards organs/tissues related to Klebsiella Pneumonia:

42
Liver, Colon, Kidney, Lung, Neutrophil, Thyroid, Bone
Sources

Publications for Klebsiella Pneumonia

About this section

Articles related to Klebsiella Pneumonia:

(show top 50) (show all 154)
# Title Authors Year
1
Prevalence of extended-spectrum-β-lactamase-producing Klebsiella pneumonia: first systematic review and meta-analysis from Iran. ( 30685458 )
2019
2
Cefquinome-Loaded Microsphere Formulations in Protection against Pneumonia with Klebsiella pneumonia Infection and Inflammatory Response in Rats. ( 30923922 )
2019
3
Changes in Gene Expression in Human Epithelial and Mast Cells in Response to Vesicles from Klebsiella pneumonia ATCC 13883. ( 31031441 )
2019
4
Regulation of NF-κB/MAPK signaling pathway attenuates the acute lung inflammation in Klebsiella pneumonia rats by mollugin treatment. ( 31075430 )
2019
5
Spinal epidural abscess caused by a community acquired extended spectrum beta lactamase producing Klebsiella pneumonia. ( 30128293 )
2018
6
Colistin-Resistant Klebsiella Infections Among Pediatric Oncology and Hematopoietic Stem Cell Transplantation Patients in Eastern India. ( 29173228 )
2018
7
In Vitro/Vivo Activity of Potential MCR-1 Inhibitor in Combination With Colistin Againsts mcr-1-Positive Klebsiella pneumonia. ( 30065720 )
2018
8
Prospective investigation of carbapenem-resistant Klebsiella pneumonia transmission among the staff, environment and patients in five major intensive care units, Beijing. ( 30529506 )
2018
9
Outcome Following the Treatment of Ventriculitis Caused by Multi/Extensive Drug Resistance Gram Negative Bacilli; Acinetobacter baumannii and Klebsiella pneumonia. ( 30728802 )
2018
10
Risk factors for acquisition of OXA-48-producing Klebsiella pneumonia among contact patients: a multicentre study. ( 28882642 )
2018
11
The frequency of Klebsiella pneumonia encoding genes for CTX-M, TEM-1 and SHV-1 extended-spectrum beta lactamases enzymes isolated from urinary tract infection. ( 29433582 )
2018
12
Cefquinome-loaded microsphere formulations against Klebsiella pneumonia infection during experimental infections. ( 29649952 )
2018
13
Whole genome sequence revealed the fine transmission map of carbapenem-resistant Klebsiella pneumonia isolates within a nosocomial outbreak. ( 29881543 )
2018
14
Prevalence of extended spectrum beta lactamase and plasmid mediated quinolone resistant genes in strains of Klebsiella pneumonia, Morganella morganii, Leclercia adecarboxylata and Citrobacter freundii isolated from poultry in South Western Nigeria. ( 29942700 )
2018
15
Tigecycline application in a 3-month-old infant with multiple drug resistant Klebsiella pneumonia: a case report. ( 29977345 )
2018
16
Prostatic abscess of Klebsiella pneumonia complicating septic pulmonary emboli and meningitis: A case report and brief review. ( 28107857 )
2017
17
Implant-associated ESBL-Klebsiella pneumonia producing small colony variant bone and joint infection in a healthy 40-year-old man. ( 28167688 )
2017
18
Epithelial Myeloid-Differentiation Factor 88 Is Dispensable during Klebsiella Pneumonia. ( 28187270 )
2017
19
Dusuqing granules (DSQ) suppress inflammation in Klebsiella pneumonia rat via NF-κB/MAPK signaling. ( 28415997 )
2017
20
Diversity-oriented sustainable synthesis of antimicrobial spiropyrrolidine/thiapyrrolizidine oxindole derivatives: New ligands for a metallo-β-lactamase from Klebsiella pneumonia. ( 28487071 )
2017
21
Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocation. ( 28493939 )
2017
22
Risk factors of mortality in bloodstream infections caused by Klebsiella pneumonia: A single-center retrospective study in China. ( 28858116 )
2017
23
Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review. ( 28758612 )
2017
24
Concurrent Endophthalmitis and Orbital Cellulitis From Metastatic Klebsiella pneumonia Liver Abscess. ( 25186218 )
2016
25
Regulator of the mucoid phenotype A gene increases the virulent ability of extended-spectrum beta-lactamase-producing serotype non-K1/K2 Klebsiella pneumonia. ( 25442871 )
2016
26
Genotyping of Klebsiella Pneumonia Strains Isolated from Eldly Inpatients by Multiple-locus Variable-number Tandem-repeat Analysis. ( 27594157 )
2016
27
Klebsiella pneumonia liver abscess syndrome: Case presentation to a college student health clinic. ( 27628340 )
2016
28
DETECTION OF CTX-M GENE ANTIBIOTICS RESISTANCE IN KLEBSIELLA PNEUMONIA ISOLATES OF HOSPITALS IN ADJARA (GEORGIA). ( 27770529 )
2016
29
Molecular Identification of Extended-Spectrum β-lactamase and Integron Genes in Klebsiella Pneumonia. ( 27935927 )
2016
30
BamB and outer membrane biogenesis - The Achilles' heel for targeting Klebsiella infections? ( 27129024 )
2016
31
Persistence of a pKPN3-like CTX-M-15-encoding IncFIIK plasmid in a Klebsiella pneumonia ST17 host during two years of intestinal colonization. ( 25738592 )
2015
32
Molecular epidemiology of aminoglycosides resistance on Klebsiella pneumonia in a hospital in China. ( 25785141 )
2015
33
An outbreak of carbapenem-resistant OXA-48 - producing Klebsiella pneumonia associated to duodenoscopy. ( 25815166 )
2015
34
Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model. ( 25874924 )
2015
35
Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates. ( 26067824 )
2015
36
Syntrophic co-culture of Bacillus subtilis and Klebsiella pneumonia for degradation of kraft lignin discharged from rayon grade pulp industry. ( 26141897 )
2015
37
Comparative whole genome transcriptome and metabolome analyses of five Klebsiella pneumonia strains. ( 26296382 )
2015
38
Emergence of Carbapenemase Producing Klebsiella Pneumonia and Spread of KPC-2 and KPC-17 in Taiwan: A Nationwide Study from 2011 to 2013. ( 26384242 )
2015
39
Klebsiella pneumonia, a Microorganism that Approves the Non-linear Responses to Antibiotics and Window Theory after Exposure to Wi-Fi 2.4 GHz Electromagnetic Radiofrequency Radiation. ( 26396967 )
2015
40
Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand. ( 26407326 )
2015
41
Chronic Klebsiella pneumonia: a rare manifestation of Klebsiella pneumonia. ( 26543615 )
2015
42
Klebsiella pneumonia: An unusual cause of ophthalmia neonatorum in a healthy newborn. ( 26691043 )
2015
43
Pharmacokinetics and ex-vivo pharmacodynamics of cefquinome against Klebsiella pneumonia in healthy dogs. ( 24372291 )
2014
44
Isolation and characterization of pyrene and benzo[a]pyrene-degrading Klebsiella pneumonia PL1 and its potential use in bioremediation. ( 24389667 )
2014
45
First report of Klebsiella pneumonia carbapenemase-producing Pseudomonas aeruginosa isolated from burn patients in Iran: phenotypic and genotypic methods. ( 24653970 )
2014
46
String test of hypervirulent Klebsiella pneumonia. ( 24890554 )
2014
47
Comparative genomic analysis of Klebsiella pneumonia (LCT-KP214) and a mutant strain (LCT-KP289) obtained after spaceflight. ( 25015528 )
2014
48
In silico identification of potential virulence genes in 1,3-propanediol producer Klebsiella pneumonia. ( 25173613 )
2014
49
Immunoproteomic to analysis the pathogenicity factors in leukopenia caused by Klebsiella pneumonia bacteremia. ( 25330314 )
2014
50
Characterization of resistance genes in 68 ESBL-producing Klebsiella pneumonia in Lebanon. ( 25453362 )
2014
Sources

Variations for Klebsiella Pneumonia

About this section
Sources

Expression for Klebsiella Pneumonia

About this section
Search GEO for disease gene expression data for Klebsiella Pneumonia.
Sources

Pathways for Klebsiella Pneumonia

About this section
Sources

GO Terms for Klebsiella Pneumonia

About this section
Sources

Sources for Klebsiella Pneumonia

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....